AWSHX
Price
$67.59
Change
-$0.49 (-0.72%)
Updated
Sep 9 closing price
Net Assets
218.5B
MNDFX
Price
$10.20
Change
-$0.04 (-0.39%)
Updated
Sep 9 closing price
Net Assets
123.21M
Interact to see
Advertisement

AWSHX vs MNDFX

AWSHX vs MNDFX Comparison Chart in %
View a ticker or compare two or three
VS
AWSHX vs. MNDFX commentary
Sep 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWSHX is a StrongBuy and MNDFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AWSHX has more cash in the bank: 218B vs. MNDFX (123M). MNDFX pays higher dividends than AWSHX: MNDFX (1.65) vs AWSHX (1.19). AWSHX was incepted earlier than MNDFX: AWSHX (74 years) vs MNDFX (18 years). MNDFX (0.57) and AWSHX (0.55) have similar cost to investors . MNDFX is a more actively managed with annual turnover of: 49.00 vs. AWSHX (32.00). AWSHX has a lower initial minimum investment than MNDFX: AWSHX (250) vs MNDFX (1000000). MNDFX annual gain was more profitable for investors over the last year : 19.60 vs. AWSHX (3.44). AWSHX return over 5 years is better than : 26.12 vs. MNDFX (19.83).
AWSHXMNDFXAWSHX / MNDFX
Total Expense Ratio0.550.5796%
Annual Report Gross Expense Ratio0.550.5796%
Fund Existence74 years18 years-
Gain YTD4.28820.46921%
Front Load6%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets218B123M177,236%
Annual Yield % from dividends1.191.6572%
Returns for 1 year3.4419.6018%
Returns for 3 years29.3733.5388%
Returns for 5 years26.1219.83132%
Returns for 10 years79.7150.23159%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QKACX57.62N/A
N/A
Federated Hermes MDT All Cap Core R6
GSGCX51.81N/A
N/A
Goldman Sachs Equity Income C
VRGWX974.21N/A
N/A
Vanguard Russell 1000 Growth Index I
JSVPX30.58N/A
N/A
JPMorgan Small Cap Value R3
VVJEX12.31N/A
N/A
Voya VACS Series MCV Fund